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Abstract
Introduction: The coronavirus disease (COVD-19) outbreak has overburdened the surveillance of severe acute respiratory infections 
(SARIs), including the laboratory network. This study was aimed at correcting the absence of laboratory results of reported SARI 
deaths. Methods: The imputation method was applied for SARI deaths without laboratory information using clinico-epidemiological 
characteristics. Results: Of 84,449 SARI deaths, 51% were confirmed with COVID-19 while 3% with other viral respiratory diseases. 
After the imputation method, 95% of deaths were reclassified as COVID-19 while 5% as other viral respiratory diseases. Conclusions: 
The imputation method was a useful and robust solution (sensitivity and positive predictive value of 98%) for missing values through 
clinical & epidemiological characteristics.
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The coronavirus disease (COVID-19) pandemic had caused 
more than 10 million cases and 500,000 deaths worldwide by 
June 20201. The severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) virus has been spreading fast globally, causing many 
severe cases and deaths. This virus has a higher basic reproduction 
number (R0) and case fatality rate (CFR) compared to influenza 
(R0: 2.5-3.3 and CFR: 0.4%-2.9% versus R0: 1.2-2.3 e CFR: 
0.15%-0.25%, respectively)2-5. In Brazil, the first confirmed case 
was reported on February 25 in Sao Paulo City, and recently at 
least one case has been reported in all Brazilian states and almost 
all municipalities (96%)6.
Brazil has a surveillance system working at three levels (federal, 
state, and municipality) of government installed in public and 
private health units for severe acute respiratory illness (SARI), and 
notification of SARI has been mandatory since 2009. The reported 
cases included patients hospitalized because of SARI at any health 
service and mild respiratory cases reported by sentinel networks 
using an online database (Influenza Epidemiological Surveillance 
Information System in Brazil - SIVEP-GRIPE). The discovery 
of SARS-CoV-2 in China and suspected cases in Brazil were 
reported using the REDCap platform, remaining until the country 
reached 1,000 confirmed cases; subsequently, a new system was 
developed (e-SUS) and used to report mild respiratory cases, and 
the SARI remained reported on SIVEP. Because of the continuity 
and consistency, SIVEP has been maintained as an official system 
to report and monitor the severe cases of COVID-19, including the 
deaths from COVID-19 independent of hospitalization.
Although SIVEP is an online platform, inconsistencies in 
monitoring and case closure opportunities persist. In addition, the 
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Ministry of Health has reported a high percentage of deaths from 
SARI without a diagnosis, called “non-specified SARI,” or alerted 
health authorities to a possible activity of other respiratory viruses 
in the Brazilian population. Therefore, this study was aimed at 
investigating the clinico-epidemiological characteristics of deaths 
from SARI reported in the Influenza Epidemiological Surveillance 
Information System in Brazil (SIVEP-Gripe) to correct the absence 
of robust laboratory results for COVID-19.
We used deaths from SARI reported in the Influenza 
Epidemiological Surveillance Information System in Brazil 
(SIVEP-Gripe) during the COVID-19 outbreak from January 1 
to June 28, 2020. The death registers were selected using the case 
evolution variable.
All reported cases were classified as follows: (i) COVID-19, 
with laboratory confirmation through the reverse-transcriptase 
polymerase chain reaction (RT-PCR) for SARS-CoV-2; (ii) 
undetected, with laboratory confirmation through RT-PCR for 
other viruses; and (iii) missing value, with no confirmation through 
RT-PCR and an indeterminate result in the processing test. This 
was considered our response variable to the regression model and 
subsequently imputed.
Before completing the data imputation method, we performed 
the logistic regression analysis to identify the variables related 
to the response. First, we applied the univariate model using the 
following predictors: signs and symptoms (fever, cough, throat pain, 
dyspnea, respiratory distress, O2 saturation < 95%, diarrhea, and 
vomiting), comorbidities (chronic cardiovascular disease, chronic 
hematological disease, chronic liver disease, asthma, diabetes 
mellitus, chronic neurological disease, other chronic pneumopathy, 
immunodeficiency/immunodepression, chronic kidney disease, and 
obesity), hospitalization (yes/no), intensive care unit stay (yes/no), 
ventilation support (invasive, non-invasive, and none), chest X-ray, 
sex, and age group (<10 years, 10 to 39 years, 40 to 59 years, 60 to 
69 years, and 70 years or more). The multiple logistic regression 
model was obtained from variables with a p-value less than 10% in 
the univariate regression model, and stepwise method was applied 
using the Akaike information criterion, Bayesian information 
criterion, and deviance. Subsequently, cases classified as “missing 
value” were subjected to a data imputation method using as 
predictors the variables selected in the multiple logistic regression.
We applied the multiple imputation method to obtain complete 
information for the “missing value” cases for the classification 
of SARI deaths. Imputation was performed using the additive 
regression method, which comprised procedures of a flexible 
additive model (nonparametric regression method) fitted on 
samples taken with replacements from original data and missing 
values (dependent variable) and predicted using non-missing values 
(independent variable obtained by multiple logistic regression)7-9.
We selected a random sample of SARI deaths that had resulted 
from COVID-19 and other viral respiratory diseases to validate 
the data imputation method. It generated randomly missing 
values for 30% of cases, and we applied the imputation method. 
Subsequently, the imputed values were compared with the observed 
values. The sensitivity, specificity, positive predictive value, 
and negative predictive value were calculated to quantify this 
validation. Furthermore, the Kappa test was performed to measure 
the concordance between the imputed and observed values. The 
significance level was considered as 5% for all analyses. All data 
were processed using R software, and the data imputation method 
was performed using the R package Hmisc.
In Brazil, from January 1 to July 28, 2020, 84,449 deaths 
from SARI were reported. Furthermore, 45,321 (54%) cases were 
confirmed using RT-PCR for some respiratory viruses, of which 
42,981 (95%) were confirmed as COVID-19. These proportions 
of confirmed COVID-19 cases were different across Brazilian 
states, with the lowest in the Mato Grosso do Sul (19%) state and 
the highest in Acre (91%) (Table 1).
Considering the overall deaths reported in Brazil, the number 
of cases undetected for respiratory viruses, indeterminate in RT-
PCR, not tested, in processing, and without information were 
21,770 (26%), 553 (1%), 2,829 (3%), 6,404 (8%), and 7,571 (9%), 
respectively; all of these cases were considered as “missing value,” 
totaling 39,128 (46%) registers. Important variations were also 
observed across Brazilian states, highlighting the following five 
states with the highest proportions of missing value: Minas Gerais 
(76%), Mato Grosso do Sul (75%), Rio Grande do Sul (73%), 
Paraná (73%), and Santa Catarina (69%) (Table 1).
In the univariate logistic regression model, the age group was 
associated with COVID-19 and positively correlated with the odds 
ratio. The signs and symptoms that showed significant associations 
were respiratory distress, fever, cough, throat pain, and dyspnea, 
all indicating inverse odds to be detected for COVID-19. Only four 
underlying health conditions presented with significant associations 
with COVID-19: chronic cardiovascular disease, diabetes mellitus, 
chronic kidney disease, and obesity. Individuals that needed 
intensive care were more likely to be detected with COVID-19. 
In the multiple logistic regression, only five variables remained in 
the final model: age group, with age of 40 years or above having 
approximately eight times more odds to be detected with COVID-19 
compared to age below 10 years; 33% chance for individuals with 
respiratory distress; 10% to 20% more chance for individuals with 
chronic cardiovascular disease and diabetes mellitus, respectively; 
and increasing chance in individuals who require ventilation support 
(32%: invasive; 38%: non-invasive) (Table 2).
Using the variables defined by the multiple logistic regression, 
the imputation method was applied for all data classified as “missing 
value.” Of the total registers classified as “missing value,” the data 
imputation method could classify 37,980 cases (97%). Furthermore, 
1,994 (2%) cases were detected with other viral respiratory diseases 
(undetected for COVID-19), and 35,986 (43%) cases were confirmed 
with COVID-19. Therefore, of the total deaths from SARI that occurred 
in Brazil from January 1 to July 28, 2020, 95% were reclassified as 
COVID-19 while 5% as some other viral respiratory disease (not 
COVID-19). Hence, all Brazilian states and federal district have at 
least 90% of deaths from SARI classified as COVID-19. Only the 
Maranhão (15%), Mato Grosso (14%), and Mato Grosso do Sul (11%) 
states presented with more than 10% of SARI deaths classified as other 
viral respiratory diseases by the imputation data method (Table 3).
To validate the data imputation method, simulation showed 
high sensitivity (99%) and positive predictive value (99%) and 
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TABLE 1: Death from severe acute respiratory illness classified by laboratory results reported by Brazilian states (Brazil, January to July, 2020)
UF
Total COVID-19 Other viral respiratory diseases Missing*
nº nº % nº % nº %
Brazil 84449 42981 51 2340 3 39128 46
AC 203 184 91 4 2 15 7
AL 1234 618 50 55 4 561 45
AM 4144 1829 44 80 2 2235 54
AP 191 94 49 0 0 97 51
BA 2824 1472 52 176 6 1176 42
CE 7579 3683 49 302 4 3594 47
DF 902 486 54 17 2 399 44
ES 1321 880 67 70 5 371 28
GO 940 401 43 34 4 505 54
MA 2530 944 37 308 12 1278 51
MG 3133 688 22 75 2 2370 76
MS 345 66 19 19 6 260 75
MT 311 99 32 29 9 183 59
PA 5825 3124 54 199 3 2502 43
PB 1470 557 38 93 6 820 56
PE 5243 3834 73 65 1 1344 26
PI 665 346 52 33 5 286 43
PR 2169 530 24 59 3 1580 73
RJ 13019 7514 58 225 2 5280 41
RN 1005 509 51 36 4 460 46
RO 247 135 55 13 5 99 40
RR 337 134 40 3 1 200 59
RS 2009 530 26 6 0 1473 73
SC 811 243 30 12 1 556 69
SE 302 168 56 18 6 116 38
SP 25411 13754 54 406 2 11251 44
TO 265 151 57 3 1 111 42
Source: SIVEP-GRIPE accessed in 06/20/2020. Notes: *included undetected results, indeterminate, not tested, in processing, ignored, and missing.
TABLE 2: Demographic information and logistic regression for death from severe acute respiratory illness confirmed to be coronavirus disease in the reverse-
transcriptase polymerase chain reaction test (Brazil, January to July, 2020).
Variables
Total COVID-19 Univariate Multivariate
nº nº % OR (95% CI) OR (95% CI)
Total 45321 42981 94.8 - -
Sex    
Male 26378 24993 94.7 1.00 -
Female 18929 17977 95.0 1.05 (0.96-1.14) -
Missing 14 11 78.6 - -
Continue...
4/6
Age group    
<10 years 224 161 71.9 1.00 1.00
10 to 39 years 2318 2141 92.4 4.73 (3.41-6.58) 5.72 (3.08-10.39)
40 to 59 years 9708 9208 94.8 7.21 (5.31-9.78) 7.71 (4.32-13.34)
60 to 69 years 10341 9826 95.0 7.47 (5.51-10.12) 8.51 (4.76-14.77)
>70 years 22730 21645 95.2 7.81 (5.80-10.51) 8.14 (4.60-13.94)
Signs and symptoms    
Respiratory distress 28634 26942 94.1 0.69 (0.61-0.78) 0.77 (0.65-0.92)
Fever 29889 28251 94.5 0.82 (0.73-0.92) -
Cough 31431 29765 94.7 0.87 (0.77-0.99) -
Throat pain 7362 6908 93.8 0.80 (0.72-0.90) -
Dyspnea 34513 32618 94.5 0.86 (0.75-0.98) -
O2 saturation <95% 29416 27821 94.6 0.95 (0.85-1.07) -
Diarrhea 4688 4453 95.0 1.03 (0.89-1.19) -
Vomit 2770 2606 94.1 0.86 (0.72-1.01) -
Comorbidities    
Chronic cardiovascular disease 17682 16926 95.7 1.25 (1.10-1.41) 1.10 (0.95-1.28)
Diabetes mellitus 14037 13397 95.4 1.15 (1.02-1.30) 1.20 (1.04-1.40)
Chronic hematological disease 521 496 95.2 1.04 (0.69-1.56) -
Chronic liver disease 590 567 96.1 1.29 (0.84-1.97) -
Asthma 935 880 94.1 0.83 (0.62-1.10) -
Chronic neurological disease 2698 2572 95.3 1.05 (0.86-1.27) -
Other chronic pneumopathy 2384 2267 95.1 1.02 (0.84-1.25) -
Immunodeficiency/immunodepression 1744 1662 95.3 1.05 (0.83-1.33) -
Chronic kidney disease 2926 2811 96.1 1.30 (1.06-1.59) -
Obesity 1700 1639 96.4 1.45 (1.11-1.89) -
Hospitalization    
No 2168 2065 95.2 1.00 -
Yes 40429 38466 95.1 0.98 (0.80-1.20) -
Missing 4892 4515 92.3 - -
Intensive care unit stay    
No 14289 13525 94.7 1.00 -
Yes 20426 19464 95.3 1.14 (1.04-1.26) -
Missing 24895 23517 94.5 - -
Ventilation support    
No 5131 4839 94.3 1.00 1.00
Yes, invasive 16944 16061 94.8 1.10 (0.96-1.26) 1.32 (1.08-1.61)
Yes, non-invasive 12065 11516 95.4 1.27 (1.09-1.47) 1.38 (1.11-1.70)
Source: SIVEP-GRIPE accessed in 06/20/2020.
TABLE 2: Continuation.
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TABLE 3: Imputed classification of death from severe acute respiratory illness by Brazilian states (Brazil, January to July, 2020).
UF
Total COVID-19 Other viral respiratory
nº nº % nº %
Brazil 84449 80022 95 4427 5
AC 203 198 98 5 2
AL 1234 1134 92 100 8
AM 4144 3956 95 188 5
AP 191 187 98 4 2
BA 2824 2579 91 245 9
CE 7579 7082 93 497 7
DF 902 869 96 33 4
ES 1321 1233 93 88 7
GO 940 878 93 62 7
MA 2530 2147 85 383 15
MG 3133 2944 94 189 6
MS 345 307 89 38 11
MT 311 267 86 44 14
PA 5825 5494 94 331 6
PB 1470 1334 91 136 9
PE 5243 5103 97 140 3
PI 665 614 92 51 8
PR 2169 2022 93 147 7
RJ 13019 12512 96 507 4
RN 1005 948 94 57 6
RO 247 231 94 16 6
RR 337 326 97 11 3
RS 2009 1924 96 85 4
SC 811 770 95 41 5
SE 302 281 93 21 7
SP 25411 24409 96 1002 4
TO 265 260 98 5 2
 Source: SIVEP-GRIPE accessed in 06/20/2020.
substantial values of specificity (71%) and negative predictive value 
(73%). Moreover, the Kappa test showed substantial concordance 
between the imputation method and the observed SARI reported 
(K= 0.71; p-value < 0.001) (Supplementary Table 1).
The absence of information in the test causing undetected cases 
of viral respiratory diseases is a bias in the information system and 
understanding the spreading of COVID-19 or other viral respiratory 
diseases in Brazil because only information about detected tests 
is reported in SIVEP-Gripe. Almost half of SARI deaths have an 
unknown cause; 26% of SARI deaths had undetected RT-PCR 
results; however, we do not know which respiratory viruses were 
tested, and more than 20% of deaths were not tested.
The simulation of the data imputation method from the real 
values proved a useful and robust solution to resolve the problem of 
the missing values or undetected results without identifying which 
respiratory viruses were tested using the clinical & epidemiological 
variables. This method presented a high sensitivity and positive 
predictive value and substantial values of specificity and negative 
predictive value, such as a moderate concordance with the real 
value using the simulation. Another way to validate this method is 
Rev Soc Bras Med Trop | on line | Vol.:53:(e20200528): 2020
6/6
selecting some imputed cases and trying to investigate the medical 
records to identify more examinations (X-ray, tomography, etc.) that 
help confirm the cases and perform retesting for these cases using 
a different methodology suitable for laboratory collection. These 
estimations should be confirmed with empirical data as the quality 
of the information systems improve.
The main limitation of this method is the associated data 
structure, i.e., if the quality of information is not reasonably good, 
the output of imputation follows this bias. With the speed of disease 
spread in the country, surveillance may compromise the quality 
of filling out epidemiological antecedents. This can explain the 
difference observed in some states that showed less than 90% of 
detected COVID-19 cases. These states usually have worse filling 
of the investigation form (Maranhão missing value for variables 
ranging from 12% to 74% while Mato Grosso and Mato Grosso do 
Sul ranging from 3% to 67%).
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SUPPLEMENTARY TABLE 1: Comparison between observed and imputed results of death from severe acute respiratory illness (Brazil, January to June, 2020).
Imputed value
Observed value
COVID-19 Other viral respiratory diseases Total
COVID-19 42363 653 43016
Other respiratory viruses 618 1687 2305
Total 42981 2340 45321
Source: SIVEP-GRIPE accessed in 06/20/2020. Notes: sensitivity = 98.6%; specificity = 71.2%; PPV = 98.4%; NPV = 73.3%.
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